{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=PASC+Post+Acute+Sequelae+of+COVID+19&page=2", "query": { "condition": "PASC Post Acute Sequelae of COVID 19", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=PASC+Post+Acute+Sequelae+of+COVID+19&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-06-11T10:51:44.267Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05615415", "title": "Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 (PASC) Using TSPO Positron Emission Tomography (PET) and MRI", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 Infection" ], "interventions": [ { "name": "PET Tracer", "type": "DRUG" }, { "name": "MRI Tracer", "type": "DRUG" }, { "name": "3T PET/MRI", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 30, "start_date": "2022-02-15", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2025-11-28", "last_synced_at": "2026-06-11T10:51:44.267Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05615415" }, { "nct_id": "NCT06928116", "title": "Heat thErapy And mobiLity in COVID-19 Survivors", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Long COVID" ], "interventions": [ { "name": "Heat therapy", "type": "BEHAVIORAL" }, { "name": "Sham Control", "type": "BEHAVIORAL" }, { "name": "Walking", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Nebraska", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "50 Years to 90 Years" }, "enrollment_count": 99, "start_date": "2025-09-17", "completion_date": "2029-08", "has_results": false, "last_update_posted_date": "2025-10-23", "last_synced_at": "2026-06-11T10:51:44.267Z", "location_count": 1, "location_summary": "Omaha, Nebraska", "locations": [ { "city": "Omaha", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT06928116" }, { "nct_id": "NCT06404086", "title": "RECOVER-SLEEP: Platform Protocol", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Long COVID", "Long COVID-19", "Hypersomnia", "Sleep Disturbance" ], "interventions": [ { "name": "Modafinil", "type": "DRUG" }, { "name": "Modafinil Placebo", "type": "DRUG" }, { "name": "Solriamfetol", "type": "DRUG" }, { "name": "Solriamfetol Placebo", "type": "DRUG" }, { "name": "Melatonin", "type": "DRUG" }, { "name": "Melantonin Placebo", "type": "DRUG" }, { "name": "Tailored lighting (TL) Active", "type": "DEVICE" }, { "name": "Tailored lighting (TL) Placebo", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 830, "start_date": "2024-07-31", "completion_date": "2025-12-31", "has_results": false, "last_update_posted_date": "2026-01-22", "last_synced_at": "2026-06-11T10:51:44.267Z", "location_count": 47, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Palo Alto, California + 31 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Palo Alto", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06404086" }, { "nct_id": "NCT05472090", "title": "A Phase 2 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Patients With Multi-Site Pain Associated With Post-Acute Sequelae of SARS-CoV-2 Infection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection", "COVID-19", "Long COVID", "Long Haul COVID" ], "interventions": [ { "name": "TNX-102 SL", "type": "DRUG" }, { "name": "Placebo SL Tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tonix Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 63, "start_date": "2022-08-18", "completion_date": "2023-07-27", "has_results": true, "last_update_posted_date": "2024-11-26", "last_synced_at": "2026-06-11T10:51:44.267Z", "location_count": 29, "location_summary": "Birmingham, Alabama • Oceanside, California • Santa Ana, California + 25 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Oceanside", "state": "California" }, { "city": "Santa Ana", "state": "California" }, { "city": "Centennial", "state": "Colorado" }, { "city": "Aventura", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05472090" }, { "nct_id": "NCT06404099", "title": "RECOVER-SLEEP: Platform Protocol, Appendix_A (Hypersomnia)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Long COVID", "Long COVID-19", "Hypersomnia" ], "interventions": [ { "name": "Modafinil", "type": "DRUG" }, { "name": "Modafinil Placebo", "type": "DRUG" }, { "name": "Solriamfetol", "type": "DRUG" }, { "name": "Solriamfetol Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 361, "start_date": "2024-08-12", "completion_date": "2026-04-20", "has_results": false, "last_update_posted_date": "2026-06-03", "last_synced_at": "2026-06-11T10:51:44.267Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT06404099" }, { "nct_id": "NCT06883513", "title": "Osteopathic Manipulative Therapy Effects on Post-Acute Sequelae of COVID-19 (PASC) or Long COVID", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Long-COVID", "PASC", "Long COVID Syndrome" ], "interventions": [ { "name": "Osteopathic Manipulative Therapy Long-COVID protocol", "type": "OTHER" }, { "name": "Osteopathic Manipulative Therapy NOT Long-COVID treatment protocol", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Louisville", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2025-05-01", "completion_date": "2025-07-03", "has_results": false, "last_update_posted_date": "2025-03-19", "last_synced_at": "2026-06-11T10:51:44.267Z", "location_count": 1, "location_summary": "Louisville, Kentucky", "locations": [ { "city": "Louisville", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT06883513" }, { "nct_id": "NCT07076862", "title": "Multiparametric [18F]F-AraG Imaging in Post-Acute Sequelae of COVID-19 (PASC)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "PASC Post Acute Sequelae of COVID-19" ], "interventions": [ { "name": "A.1 - [¹⁸F]F-AraG PET/CT (90-min dynamic + 4-h static)", "type": "DRUG" }, { "name": "A.2 - [¹⁸F]F-AraG PET/CT (60-min dynamic only)", "type": "DRUG" }, { "name": "B.1 - [¹⁸F]F-AraG PET/CT (90-min dynamic + 4-h static)", "type": "DRUG" }, { "name": "B.2 - [¹⁸F]F-AraG PET/CT (60-min dynamic only)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, Davis", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 51, "start_date": "2025-12-04", "completion_date": "2029-12", "has_results": false, "last_update_posted_date": "2026-05-22", "last_synced_at": "2026-06-11T10:51:44.267Z", "location_count": 2, "location_summary": "Sacramento, California • San Francisco, California", "locations": [ { "city": "Sacramento", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07076862" }, { "nct_id": "NCT06156202", "title": "Evaluating a Comprehensive Multimodal Outpatient Rehabilitation Program for PASC Program to Improve Functioning of Persons Suffering From Post-COVID-19 Syndrome: A Randomized Controlled Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Post-Acute COVID-19", "Post-Acute COVID-19 Syndrome", "Post-Acute COVID-19 Infection", "Long COVID", "Long Covid19", "Dyspnea", "Orthostasis", "Cognitive Impairment" ], "interventions": [ { "name": "Comprehensive Rehabilitation", "type": "OTHER" }, { "name": "Augmented Usual Care", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 125, "start_date": "2023-11-15", "completion_date": "2025-11-30", "has_results": false, "last_update_posted_date": "2026-01-20", "last_synced_at": "2026-06-11T10:51:44.267Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT06156202" }, { "nct_id": "NCT05965739", "title": "RECOVER-NEURO: Platform Protocol, Appendix_A to Measure the Effects of BrainHQ, PASC CoRE and tDCS Interventions on Long COVID Symptoms", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Long COVID", "Long Covid19", "Long Covid-19" ], "interventions": [ { "name": "BrainHQ/Active Comparator Activity", "type": "OTHER" }, { "name": "BrainHQ", "type": "OTHER" }, { "name": "PASC CoRE", "type": "OTHER" }, { "name": "tDCS-active", "type": "DEVICE" }, { "name": "tDCS-sham", "type": "DEVICE" } ], "intervention_types": [ "OTHER", "DEVICE" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 328, "start_date": "2023-09-01", "completion_date": "2024-12-17", "has_results": false, "last_update_posted_date": "2025-05-04", "last_synced_at": "2026-06-11T10:51:44.267Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05965739" }, { "nct_id": "NCT07090564", "title": "Treatment Outcomes in PASC Patients With Neurocognitive Impairment", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Long COVID" ], "interventions": [], "intervention_types": [], "sponsor": "Ohio State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 171, "start_date": "2022-10-12", "completion_date": "2024-04-01", "has_results": false, "last_update_posted_date": "2026-03-03", "last_synced_at": "2026-06-11T10:51:44.267Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT07090564" } ] }